<DOC>
	<DOCNO>NCT01322321</DOCNO>
	<brief_summary>This study ass safety efficacy ACZ885 stimulate C-peptide mixed meal test patient newly-diagnosed type 1 diabetes mellitus .</brief_summary>
	<brief_title>ACZ885 Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>diagnosis type 1 diabetes within 3 month visit 1 stable insulin regimen presence least one diabetesrelated autoantibody qualify Cpeptide value mixed meal test visit 1 willing vaccination live vaccine 18 month , 3 month visit 1 3 month last dose study drug body weight least 30 kg woman childbearing potential unless highly effective method birth control use ( combined oral contraceptive , intrauterine device , etc ) immunodeficiency active infection febrile illness within 3 day visit 1 major dental work within 8 day visit 1 positive test tuberculosis visit 1 use medication insulin treatment diabetes Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>ACZ885</keyword>
	<keyword>diabetes</keyword>
	<keyword>type 1</keyword>
	<keyword>C-peptide</keyword>
</DOC>